FINNENCE ▪ THE WIRE FILE
THE WIRE · № 73054
News▼ Bearish
SciBase's rights issue registered, conversion of BTA into shares
KINDNews
DIRECTION▼ Bearish
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-09 13:19 UTC
LAST UPDATE2026-10-09 13:19 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A small rights issue dilutes holders and signals strained funding for the medtech firm.
SciBase raises SEK 57.5m via dilutive rights issue
CATALYST TO WATCH
BTA conversion and new share listing
MAIN RISK
Dilution pressures an already small-cap stock
FULL DISPATCH
STOCKHOLM, Oct. 9, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") announces that the rights issue of shares of approximately SEK 57.5 million resolved by the Board of Directors on 3 September 2026, the outcome of which was announced on 1 October 2026 (the...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDEurope
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Europe
GAC Goes Deeper in Europe -- the "New Chapter" to Be Unveiled at the 2026 Paris Motor Show2026-10-09 13:28 UTC
GAC Goes Deeper in Europe -- the "New Chapter" to Be Unveiled at the 2026 Paris Motor Show2026-10-09 13:28 UTC
→CORRELATIONshares Healthcare
Insurance Leaders Convene to Shape the Future of Claims and Underwriting in the Age of AI2026-10-09 13:34 UTC
Insurance Leaders Convene to Shape the Future of Claims and Underwriting in the Age of AI2026-10-09 13:34 UTC
→CORRELATIONshares Europe
EU, China agree deal on hybrid vehicle trade, pledge export-control cooperation2026-10-09 13:42 UTC
EU, China agree deal on hybrid vehicle trade, pledge export-control cooperation2026-10-09 13:42 UTC
←CORRELATIONshares Europe
Fragile Calm Returns to Europe Bond Market After French Turmoil2026-10-09 09:08 UTC
Fragile Calm Returns to Europe Bond Market After French Turmoil2026-10-09 09:08 UTC
←CORRELATIONshares Healthcare
Iambic sets IPO terms, seeking $150 million to advance AI-designed cancer drugs2026-10-09 11:15 UTC
Iambic sets IPO terms, seeking $150 million to advance AI-designed cancer drugs2026-10-09 11:15 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.